AngioGenex, Inc.·5

Jan 8, 8:24 PM ET

Garland William A 5

5 · AngioGenex, Inc. · Filed Jan 8, 2010

Insider Transaction Report

Form 5
Period: 2009-12-31
Garland William A
DirectorCEO, COO
Transactions
  • Award

    Non-Statutory Stock Options

    2009-07-09+2,300,0002,770,000 total
    Exercise: $0.05From: 2009-07-09Exp: 2019-07-09Common Stock (2,300,000 underlying)
Holdings
  • Common Stock

    795,000

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT